274 related articles for article (PubMed ID: 9391102)
21. The tumor suppressor protein Fhit. A novel interaction with tubulin.
Chaudhuri AR; Khan IA; Prasad V; Robinson AK; Ludueña RF; Barnes LD
J Biol Chem; 1999 Aug; 274(34):24378-82. PubMed ID: 10446217
[TBL] [Abstract][Full Text] [Related]
22. An FHIT tumor suppressor gene?
Le Beau MM; Drabkin H; Glover TW; Gemmill R; Rassool FV; McKeithan TW; Smith DI
Genes Chromosomes Cancer; 1998 Apr; 21(4):281-9. PubMed ID: 9559339
[TBL] [Abstract][Full Text] [Related]
23. Induction of the common fragile site FRA3B does not affect FHIT expression.
Michael D; Rajewsky MF
Oncogene; 2001 Mar; 20(14):1798-801. PubMed ID: 11313927
[TBL] [Abstract][Full Text] [Related]
24. Role of FHIT in human cancer.
Croce CM; Sozzi G; Huebner K
J Clin Oncol; 1999 May; 17(5):1618-24. PubMed ID: 10334551
[TBL] [Abstract][Full Text] [Related]
25. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas.
Bugert P; Wilhelm M; Kovacs G
Genes Chromosomes Cancer; 1997 Sep; 20(1):9-15. PubMed ID: 9290948
[TBL] [Abstract][Full Text] [Related]
26. Homozygous deletion but not mutation of exons 5 and 8 of the fragile histidine triad (FHIT) gene is associated with features of differentiated thyroid carcinoma.
Yin DT; Wang L; Sun J; Yin F; Yan Q; Shen RL; Gao JX; He G
Ann Clin Lab Sci; 2010; 40(3):267-72. PubMed ID: 20689140
[TBL] [Abstract][Full Text] [Related]
27. Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B.
Boldog F; Gemmill RM; West J; Robinson M; Robinson L; Li E; Roche J; Todd S; Waggoner B; Lundstrom R; Jacobson J; Mullokandov MR; Klinger H; Drabkin HA
Hum Mol Genet; 1997 Feb; 6(2):193-203. PubMed ID: 9063739
[TBL] [Abstract][Full Text] [Related]
28. Engineering human Fhit, a diadenosine triphosphate hydrolase, into an efficient dinucleoside polyphosphate synthase.
Huang K; Frey PA
J Am Chem Soc; 2004 Aug; 126(31):9548-9. PubMed ID: 15291552
[TBL] [Abstract][Full Text] [Related]
29. FHIT as tumor suppressor: mechanisms and therapeutic opportunities.
Pekarsky Y; Palamarchuk A; Huebner K; Croce CM
Cancer Biol Ther; 2002; 1(3):232-6. PubMed ID: 12432269
[TBL] [Abstract][Full Text] [Related]
30. The Fragile Histidine Triad gene and breast cancer.
Yang Q; Yoshimura G; Sakurai T; Kakudo K
Med Sci Monit; 2002 Jul; 8(7):RA140-4. PubMed ID: 12118213
[TBL] [Abstract][Full Text] [Related]
31. Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in breast cancer cell lines.
Sevignani C; Calin GA; Cesari R; Sarti M; Ishii H; Yendamuri S; Vecchione A; Trapasso F; Croce CM
Cancer Res; 2003 Mar; 63(6):1183-7. PubMed ID: 12649173
[TBL] [Abstract][Full Text] [Related]
32. Common chromosomal fragile sites and cancer: focus on FRA16D.
O'Keefe LV; Richards RI
Cancer Lett; 2006 Jan; 232(1):37-47. PubMed ID: 16242840
[TBL] [Abstract][Full Text] [Related]
33. Association of FHIT (fragile histidine triad), a candidate tumour suppressor gene, with the ubiquitin-conjugating enzyme hUBC9.
Shi Y; Zou M; Farid NR; Paterson MC
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):443-8. PubMed ID: 11085938
[TBL] [Abstract][Full Text] [Related]
34. The murine Fhit gene is highly similar to its human orthologue and maps to a common fragile site region.
Glover TW; Hoge AW; Miller DE; Ascara-Wilke JE; Adam AN; Dagenais SL; Wilke CM; Dierick HA; Beer DG
Cancer Res; 1998 Aug; 58(15):3409-14. PubMed ID: 9699673
[TBL] [Abstract][Full Text] [Related]
35. Components of DNA damage checkpoint pathway regulate UV exposure-dependent alterations of gene expression of FHIT and WWOX at chromosome fragile sites.
Ishii H; Mimori K; Inageta T; Murakumo Y; Vecchione A; Mori M; Furukawa Y
Mol Cancer Res; 2005 Mar; 3(3):130-8. PubMed ID: 15798093
[TBL] [Abstract][Full Text] [Related]
36. Sequence of the FRA3B common fragile region: implications for the mechanism of FHIT deletion.
Inoue H; Ishii H; Alder H; Snyder E; Druck T; Huebner K; Croce CM
Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14584-9. PubMed ID: 9405656
[TBL] [Abstract][Full Text] [Related]
37. Identification of novel 'expressed sequence tags' within the FHIT gene locus in human chromosome region 3p14.2.
Lux A; Bardenheuer W; Michael D; Bröcker F; Jülicher K; Vieten L; Michaelis S; Seeber S; Opalka B; Schütte J
Hum Genet; 1997 Jul; 100(1):90-5. PubMed ID: 9225975
[TBL] [Abstract][Full Text] [Related]
38. Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas.
Michael D; Beer DG; Wilke CW; Miller DE; Glover TW
Oncogene; 1997 Oct; 15(14):1653-9. PubMed ID: 9349498
[TBL] [Abstract][Full Text] [Related]
39. The Fhit tumor suppressor protein regulates the intracellular concentration of diadenosine triphosphate but not diadenosine tetraphosphate.
Murphy GA; Halliday D; McLennan AG
Cancer Res; 2000 May; 60(9):2342-4. PubMed ID: 10811104
[TBL] [Abstract][Full Text] [Related]
40. Genetic, biochemical, and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit.
Pace HC; Garrison PN; Robinson AK; Barnes LD; Draganescu A; Rösler A; Blackburn GM; Siprashvili Z; Croce CM; Huebner K; Brenner C
Proc Natl Acad Sci U S A; 1998 May; 95(10):5484-9. PubMed ID: 9576908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
